Stockreport

ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch [Yahoo! Finance]

Zenas BioPharma, Inc.  (ZBIO) 
PDF BioPharma (NASDAQ:ZBIO) , an estimated $5.19 million trade based on quarterly average pricing. ENAVATE Sciences added 157,800 shares of Zenas BioPharma, an estimated $ [Read more]